Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Neuroendocrine Tumors A Critical Appraisal of Management Strategies

Neuroendocrine Tumors A Critical Appraisal of Management Strategies CONFERENCE REPORT: NETS SUMMIT Neuroendocrine Tumors A Critical Appraisal of Management Strategies Aaron I. Vinik, MD, PhD, FCP, MACP,* Lowell Anthony, MD,Þ J. Philip Boudreaux, MD, FACS,Þþ Vay Liang W. Go, MD,§ Thomas M. O’Dorisio, MD,|| Philippe Ruszniewski, MD,¶ and Eugene A. Woltering, MD, FACSÞ regional or distant metastases, increasing from 30 to 120 months Objectives: This supplement represents the proceedings of a panel of and to more than 120 months if localized. There is no doubt investigators whose goal was to assess the quality of evidence pertain- that early recognition is of the utmost essence. Early studies ing to current therapeutic approaches in the management of neuroendo- show that the median time from first appearance of symptoms to crine tumors (NETs). It will examine the differences in opinions between diagnosis was 9.2 years. Clearly, a greater index of suspicion is expert faculty and community physicians. necessary. Practitioners have little desire to diagnose conditions Methods: The Neuroendocrine Tumors Summit convened in December for which they have no ready solution. It recently was stated 2009 to address 6 statements prepared by panel members that reflect that over the last 30 years, there has been a Brapid pace of no important http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pancreas Wolters Kluwer Health

Neuroendocrine Tumors A Critical Appraisal of Management Strategies

Download PDF
18 pages

Loading next page...
 
/lp/wolters-kluwer-health/neuroendocrine-tumors-a-critical-appraisal-of-management-strategies-F0Pa4JrrCj

References (94)

ISSN
0885-3177
eISSN
1536-4828
DOI
10.1097/MPA.0b013e3181ea5839
pmid
20664478
Publisher site
See Article on Publisher Site

Abstract

CONFERENCE REPORT: NETS SUMMIT Neuroendocrine Tumors A Critical Appraisal of Management Strategies Aaron I. Vinik, MD, PhD, FCP, MACP,* Lowell Anthony, MD,Þ J. Philip Boudreaux, MD, FACS,Þþ Vay Liang W. Go, MD,§ Thomas M. O’Dorisio, MD,|| Philippe Ruszniewski, MD,¶ and Eugene A. Woltering, MD, FACSÞ regional or distant metastases, increasing from 30 to 120 months Objectives: This supplement represents the proceedings of a panel of and to more than 120 months if localized. There is no doubt investigators whose goal was to assess the quality of evidence pertain- that early recognition is of the utmost essence. Early studies ing to current therapeutic approaches in the management of neuroendo- show that the median time from first appearance of symptoms to crine tumors (NETs). It will examine the differences in opinions between diagnosis was 9.2 years. Clearly, a greater index of suspicion is expert faculty and community physicians. necessary. Practitioners have little desire to diagnose conditions Methods: The Neuroendocrine Tumors Summit convened in December for which they have no ready solution. It recently was stated 2009 to address 6 statements prepared by panel members that reflect that over the last 30 years, there has been a Brapid pace of no important

Journal

Pancreas – Wolters Kluwer Health

Published: Aug 1, 2010

There are no references for this article.